Phase
Condition
Panic Disorders
Anxiety Disorders
Mood Disorders
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult male and female subjects with primary DSM-IV diagnosis of GAD, as confirmed bythe MINI structured interview.
- Historical failure to respond optimally to a GAD treatment
Exclusion
Exclusion Criteria:
- Current primary DSM-IV (Diagnostic and Statistical Manual of Mental Disorders 4thedition) diagnosis of major depressive disorder with or without seasonal pattern,dysthmic disorder, depressive disorder NOS (not otherwise specified), social phobia,panic disorder with or without agoraphobia, post traumatic stress disorder,dissociative disorder, borderline personality disorder, obsessive-compulsive disorder,antisocial personality disorder, as defined in the DSM-IV TR (Diagnostic andStatistical Manual of Mental Disorders 4th edition, Text Revision).
- Past and/or current DSM-IV diagnosis of schizophrenia, schizoaffective disorder, otherpsychotic disorders, bipolar disorders (I or II), factitious disorder or cognitivedisorder (including delirium, dementia, and amnestic disorder).
Study Design
Study Description
Connect with a study center
Pfizer Investigational Site
Brno, 602 00
CzechiaSite Not Available
Pfizer Investigational Site
Litomerice, 412 01
CzechiaSite Not Available
Pfizer Investigational Site
Praha 2, 120 00
CzechiaSite Not Available
Pfizer Investigational Site
Praha 5, 158 00
CzechiaSite Not Available
Pfizer Investigational Site
Praha 6, 163 00
CzechiaSite Not Available
Pfizer Investigational Site
Praha 8 - Bohnice, 181 03
CzechiaSite Not Available
Pfizer Investigational Site
Viljandi, Viljandi Mk. 71024
EstoniaSite Not Available
Pfizer Investigational Site
Tallinn, 10614
EstoniaSite Not Available
Pfizer Investigational Site
Tartu, 50417
EstoniaSite Not Available
Pfizer Investigational Site
Helsinki, 00029 HUS
FinlandSite Not Available
Pfizer Investigational Site
Joensuu, 80100
FinlandSite Not Available
Pfizer Investigational Site
Kuopio, 70110
FinlandSite Not Available
Pfizer Investigational Site
Budapest, 1083
HungarySite Not Available
Pfizer Investigational Site
Pecs, 7623
HungarySite Not Available
Pfizer Investigational Site
Moscow, 115522
Russian FederationSite Not Available
Pfizer Investigational Site
Smolensk, 214018
Russian FederationSite Not Available
Pfizer Investigational Site
St Petersburg, 190121
Russian FederationSite Not Available
Pfizer Investigational Site
St. Petersburg, 191180
Russian FederationSite Not Available
Pfizer Investigational Site
Belgrade, 11000
SerbiaSite Not Available
Pfizer Investigational Site
Kragujevac, 34000
SerbiaSite Not Available
Pfizer Investigational Site
Dnipropetrovsk, 49005
UkraineSite Not Available
Pfizer Investigational Site
Donetsk, 83037
UkraineSite Not Available
Pfizer Investigational Site
Kyiv, 01030
UkraineSite Not Available
Pfizer Investigational Site
Lugansk, 91045
UkraineSite Not Available
Pfizer Investigational Site
Lviv, 79021
UkraineSite Not Available
Pfizer Investigational Site
Arcadia, California 91007-3462
United StatesSite Not Available
Pfizer Investigational Site
Burbank, California 91506
United StatesSite Not Available
Pfizer Investigational Site
Redlands, California 92374
United StatesSite Not Available
Pfizer Investigational Site
Sherman Oaks, California 91403
United StatesSite Not Available
Pfizer Investigational Site
Norwich, Connecticut 06360
United StatesSite Not Available
Pfizer Investigational Site
Destin, Florida 32541
United StatesSite Not Available
Pfizer Investigational Site
Fort Walton Beach, Florida 32547
United StatesSite Not Available
Pfizer Investigational Site
Miami, Florida 33143
United StatesSite Not Available
Pfizer Investigational Site
South Miami, Florida 33143
United StatesSite Not Available
Pfizer Investigational Site
Overland Park, Kansas 66212
United StatesSite Not Available
Pfizer Investigational Site
Wichita, Kansas 67207
United StatesSite Not Available
Pfizer Investigational Site
Shreveport, Louisiana 71104
United StatesSite Not Available
Pfizer Investigational Site
Baltimore, Maryland 21208
United StatesSite Not Available
Pfizer Investigational Site
Boston, Massachusetts 02114
United StatesSite Not Available
Pfizer Investigational Site
Olive Branch, Mississippi 38654
United StatesSite Not Available
Pfizer Investigational Site
Saint Charles, Missouri 63301
United StatesSite Not Available
Pfizer Investigational Site
St. Charles, Missouri 63301
United StatesSite Not Available
Pfizer Investigational Site
Omaha, Nebraska 68131
United StatesSite Not Available
Pfizer Investigational Site
Clementon, New Jersey 08021
United StatesSite Not Available
Pfizer Investigational Site
Albuquerque, New Mexico 87102
United StatesSite Not Available
Pfizer Investigational Site
New York, New York 10128-1708
United StatesSite Not Available
Pfizer Investigational Site
Beachwood, Ohio 44122
United StatesSite Not Available
Pfizer Investigational Site
Cincinnati, Ohio 45227
United StatesSite Not Available
Pfizer Investigational Site
Cleveland, Ohio 44109-1998
United StatesSite Not Available
Pfizer Investigational Site
Bala Cynwyd, Pennsylvania 19004
United StatesSite Not Available
Pfizer Investigational Site
Bala-Cynwyd, Pennsylvania 19004
United StatesSite Not Available
Pfizer Investigational Site
Media, Pennsylvania 19063
United StatesSite Not Available
Pfizer Investigational Site
Philadelphia, Pennsylvania 19136
United StatesSite Not Available
Pfizer Investigational Site
Columbia, South Carolina 29201
United StatesSite Not Available
Pfizer Investigational Site
Memphis, Tennessee 38133
United StatesSite Not Available
Pfizer Investigational Site
Houston, Texas 77008
United StatesSite Not Available
Pfizer Investigational Site
Lake Jackson, Texas 77566
United StatesSite Not Available
Pfizer Investigational Site
Waukesha, Wisconsin 53188-1660
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.